SynDRA canonical compound SYN0005975 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · Rx/OTC |
| Primary target(s) | NR3C2 |
| Mechanism of action | Mineralocorticoid receptor antagonist |
| Indication | congestive heart failure | hepatic cirrhosis | hyperaldosteronism | hypertension | hypokalemia | nephrotic syndrome |
| Disease area | cardiology | endocrinology | gastroenterology | rheumatology |